Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

83 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
COVID-19 and Mixed Cryoglobulinemia Syndrome: Long-Term Survey Study on the Prevalence and Outcome, Vaccine Safety, and Immunogenicity.
Gragnani L, Visentini M, Lorini S, Santini SA, Lauletta G, Mazzaro C, Urraro T, Quartuccio L, Cacciapaglia F, Ruscitti P, Tavoni A, Marri S, Cusano G, Petraccia L, Naclerio C, Treppo E, Del Frate G, Di Cola I, Raimondo V, Scorpiniti D, Monti M, Puccetti L, Elia G, Fallahi P, Basili S, Scarpato S, Iannone F, Casato M, Antonelli A, Zignego AL, Ferri C. Gragnani L, et al. Among authors: casato m. J Clin Immunol. 2023 May;43(4):680-691. doi: 10.1007/s10875-023-01444-4. Epub 2023 Feb 16. J Clin Immunol. 2023. PMID: 36795264 Free PMC article.
HCV infection in a patient with hyper IgM syndrome.
Quinti I, Giovannetti A, Paganelli R, Pucillo LP, Varani AR, Ricci G, Scala E, Pandolfi F, Casato M, Aiuti F. Quinti I, et al. Among authors: casato m. J Clin Immunol. 1996 Nov;16(6):321-5. doi: 10.1007/BF01541667. J Clin Immunol. 1996. PMID: 8946276
Efficacy of low-dose rituximab for mixed cryoglobulinemia.
Visentini M, Granata M, Veneziano ML, Borghese F, Carlesimo M, Pimpinelli F, Fiorilli M, Casato M. Visentini M, et al. Among authors: casato m. Clin Immunol. 2007 Oct;125(1):30-3. doi: 10.1016/j.clim.2007.06.008. Epub 2007 Aug 9. Clin Immunol. 2007. PMID: 17692572 Clinical Trial.
A phase II, single-arm multicenter study of low-dose rituximab for refractory mixed cryoglobulinemia secondary to hepatitis C virus infection.
Visentini M, Ludovisi S, Petrarca A, Pulvirenti F, Zaramella M, Monti M, Conti V, Ranieri J, Colantuono S, Fognani E, Piluso A, Tinelli C, Zignego AL, Mondelli MU, Fiorilli M, Casato M. Visentini M, et al. Among authors: casato m. Autoimmun Rev. 2011 Sep;10(11):714-9. doi: 10.1016/j.autrev.2011.04.033. Epub 2011 May 5. Autoimmun Rev. 2011. PMID: 21570494 Clinical Trial.
Efficacy of low-dose rituximab for the treatment of mixed cryoglobulinemia vasculitis: Phase II clinical trial and systematic review.
Visentini M, Tinelli C, Colantuono S, Monti M, Ludovisi S, Gragnani L, Mitrevski M, Ranieri J, Fognani E, Piluso A, Granata M, De Silvestri A, Scotti V, Mondelli MU, Zignego AL, Fiorilli M, Casato M. Visentini M, et al. Among authors: casato m. Autoimmun Rev. 2015 Oct;14(10):889-96. doi: 10.1016/j.autrev.2015.05.013. Epub 2015 May 29. Autoimmun Rev. 2015. PMID: 26031898 Clinical Trial.
83 results